Search

Your search keyword '"Nayak, Lingaraj"' showing total 362 results

Search Constraints

Start Over You searched for: Author "Nayak, Lingaraj" Remove constraint Author: "Nayak, Lingaraj"
362 results on '"Nayak, Lingaraj"'

Search Results

1. Treatment challenges and outcomes of older patients with acute myeloid leukemia from India

2. Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer Centre

4. A Prospective Study to Evaluate the Effect of Therapeutic Drug Monitoring-Based Posaconazole Prophylaxis on Invasive Fungal Infection Rate During Acute Myeloid Leukemia Induction Therapy

8. Clinical Utility of Stepwise Bronchoalveolar Lavage Fluid Analysis in Diagnosing and Managing Lung Infiltrates in Leukemia/Lymphoma Patients With Febrile Neutropenia

12. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect

16. Outcomes of COVID-19 and risk factors in patients with cancer

17. Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant

19. Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings

22. Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation.

23. Dosimetric Impact of Voluntary Deep Inspiration Breath Hold (DIBH) in Mediastinal Hodgkin Lymphomas: A Comparative Evaluation of Three Different Intensity Modulated Radiation Therapy (IMRT) Delivery Methods Using Voluntary DIBH and Free Breathing Techniques

24. Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study

25. Withania Somnifera Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect

27. Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India

31. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis

32. P-163 Treatment patterns and outcomes in newly diagnosed multiple myeloma

33. P-151 Demographic and clinical characteristics of multiple myeloma patients in a tertiary cancer institute of India

34. P-160 Real world data on demographics, management and outcome of ultra high risk myeloma: experience from a tertiary care centre

41. Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL)

43. P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.

44. NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies

45. A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome

46. A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1

47. Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy

48. A retrospective observational study to evaluate the reliability of staging and risk stratification of adolescent and adult patients with Hodgkin’s lymphoma registered at the lymphoma clinic of a tertiary cancer center in Western India

Catalog

Books, media, physical & digital resources